How the Viral Neanderthal-Baby Story Turned Real Science into Junk Journalism

When Harvard geneticist George Church sat down for a casual interview with a German magazine, he wasn't trying to send out the message, " Mad Scientist Seeks Lady To Give Birth To Neanderthal Monster ." So how did the media - and The Daily Mail in particular - take a level-headed discussion about the future of cloning and turn it into a story about ... (more)

http://www.theatlanticwire.com/technology/2013/01/neanderthal-baby-story/61274/

Americaa s Exodus from Marriage

... and theology. In its inaugural report, the Council examines the last decade's contentious debates over stem cell research - exposing the major lies and distortions, clarifying the scientific promise and ethical stakes of the research, and drawing ...

http://eppc.org/publications/pubID.4930/pub_detail.asp

Researchers Turn One Form of Neuron into Another in the Brain

A new finding by Harvard stem cell biologists turns one of the basics of neurobiology on its head by demonstrating that it is possible to turn one type of already differentiated neuron into another within the brain.

http://www.biosciencetechnology.com/news/2013/01/researchers-turn-one-form-neuron-another-brain

Morning Buzz: Post Inaugural Random Thoughts

... You don't clone a species that's extinct. Jokes aside, this is the nightmare a lot of people opposed to stem cell research envisioned. I can't imagine a reason to clone humans. It is such a fine line because I don't think a lot of people would ...

http://www.msnbc.msn.com/id/50550347/ns/local_news-des_moines_ia/

Japan's stimulus package showers science with cash

Three years ago, the picture for research funding in Japan looked bleak. As part of efforts to slash the national budget by A 3 trillion , the government, led by the Democratic Party of Japan, had proposed sweeping cuts to science, sparking protests from the country's most eminent researchers.

http://www.nature.com/news/japan-s-stimulus-package-showers-science-with-cash-1.12270

VistaGen Therapeutics, Inc. to Present at Ninth Annual Equity Conference

VistaGen Therapeutics, Inc. , a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced that Shawn K. Singh, CEO of VistaGen, will present at Noble Financial Capital Markets' Ninth Annual Equity Conference.

http://www.biospace.com/news_story.aspx?StoryID=285282&full=1

Morning Buzz: Post Inaugural Random Thoughts

... You don't clone a species that's extinct. Jokes aside, this is the nightmare a lot of people opposed to stem cell research envisioned. I can't imagine a reason to clone humans. It is such a fine line because I don't think a lot of people would ...

http://whotv.com/2013/01/22/post-inaugural-random-thoughts/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+wholocalnews+%28WHOtv.com+-+Iowa+headlines%29